Bone Metastases and Skeletal-Related Events in Medullary Thyroid Carcinoma.
Bone metastases (BM) can lead to devastating skeletal-related events (SREs) in cancer patients. Data regarding medullary thyroid carcinoma (MTC) with BM are lacking.



We evaluated the natural history of BM and SREs in MTC patients identified by a cancer center tumor registry.



The study was conducted at a tertiary cancer center.



We retrospectively reviewed the charts of MTC patients with BM who received care from 1991 to 2014 to characterize BM and SREs.



Of 1008 MTC patients treated, 188 were confirmed to have BM (19%), of whom 89% (168 of 188) had nonosseous distant metastases. Median time from MTC to BM diagnosis was 30.9 months (range 0-533 mo); 25% (45 of 180) had BM identified within 3 months of MTC diagnosis. Median follow-up after detecting BM was 1.6 years (range 0-23.2 y). Most patients (77%) had six or more BM lesions, most often affecting the spine (92%) and pelvis (69%). Many patients (90 of 188, 48%) experienced one or more SREs, most commonly radiotherapy (67 of 90, 74%) followed by pathological fracture (21 of 90, 23%). Only three patients had spinal cord compression. Patients with more than 10 BM lesions were more likely to experience SREs (odds ratio 2.4; P = .007), with no difference in 5-year mortality after MTC diagnosis between patients with (31%) and without SREs (23%) (P = .11).



In this large retrospective series, BM in MTC was multifocal, primarily involving the spine and pelvis, supporting screening these regions for metastases in at-risk patients. SREs were common but spinal cord compression was rare. Antiresorptive therapies in this population should be investigated further with prospective trials.
Departments of Endocrine Neoplasia and Hormonal Disorders (J.Y.X., C.J., S.N.R., M.A.H., S.G.W., R.D., R.F.G., A.K.Y., M.E.C., S.P.W., N.L.B., R.V.S., S.I.S., M.I.H.), Radiology (W.A.M.), Biostatistics (D.R.M.), and Endocrine Surgery (E.G.), University of Texas MD Anderson Cancer Center, Houston, Texas 77230-1402.
Jian Yu
JY
Xu
Departments of Endocrine Neoplasia and Hormonal Disorders (J.Y.X., C.J., S.N.R., M.A.H., S.G.W., R.D., R.F.G., A.K.Y., M.E.C., S.P.W., N.L.B., R.V.S., S.I.S., M.I.H.), Radiology (W.A.M.), Biostatistics (D.R.M.), and Endocrine Surgery (E.G.), University of Texas MD Anderson Cancer Center, Houston, Texas 77230-1402.
William A
WA
Murphy
Departments of Endocrine Neoplasia and Hormonal Disorders (J.Y.X., C.J., S.N.R., M.A.H., S.G.W., R.D., R.F.G., A.K.Y., M.E.C., S.P.W., N.L.B., R.V.S., S.I.S., M.I.H.), Radiology (W.A.M.), Biostatistics (D.R.M.), and Endocrine Surgery (E.G.), University of Texas MD Anderson Cancer Center, Houston, Texas 77230-1402.
Denái R
DR
Milton
Departments of Endocrine Neoplasia and Hormonal Disorders (J.Y.X., C.J., S.N.R., M.A.H., S.G.W., R.D., R.F.G., A.K.Y., M.E.C., S.P.W., N.L.B., R.V.S., S.I.S., M.I.H.), Radiology (W.A.M.), Biostatistics (D.R.M.), and Endocrine Surgery (E.G.), University of Texas MD Anderson Cancer Center, Houston, Texas 77230-1402.
Camilo
C
Jimenez
Departments of Endocrine Neoplasia and Hormonal Disorders (J.Y.X., C.J., S.N.R., M.A.H., S.G.W., R.D., R.F.G., A.K.Y., M.E.C., S.P.W., N.L.B., R.V.S., S.I.S., M.I.H.), Radiology (W.A.M.), Biostatistics (D.R.M.), and Endocrine Surgery (E.G.), University of Texas MD Anderson Cancer Center, Houston, Texas 77230-1402.
Sarika N
SN
Rao
Departments of Endocrine Neoplasia and Hormonal Disorders (J.Y.X., C.J., S.N.R., M.A.H., S.G.W., R.D., R.F.G., A.K.Y., M.E.C., S.P.W., N.L.B., R.V.S., S.I.S., M.I.H.), Radiology (W.A.M.), Biostatistics (D.R.M.), and Endocrine Surgery (E.G.), University of Texas MD Anderson Cancer Center, Houston, Texas 77230-1402.
Mouhammed Amir
MA
Habra
Departments of Endocrine Neoplasia and Hormonal Disorders (J.Y.X., C.J., S.N.R., M.A.H., S.G.W., R.D., R.F.G., A.K.Y., M.E.C., S.P.W., N.L.B., R.V.S., S.I.S., M.I.H.), Radiology (W.A.M.), Biostatistics (D.R.M.), and Endocrine Surgery (E.G.), University of Texas MD Anderson Cancer Center, Houston, Texas 77230-1402.
Steven G
SG
Waguespack
Departments of Endocrine Neoplasia and Hormonal Disorders (J.Y.X., C.J., S.N.R., M.A.H., S.G.W., R.D., R.F.G., A.K.Y., M.E.C., S.P.W., N.L.B., R.V.S., S.I.S., M.I.H.), Radiology (W.A.M.), Biostatistics (D.R.M.), and Endocrine Surgery (E.G.), University of Texas MD Anderson Cancer Center, Houston, Texas 77230-1402.
Ramona
R
Dadu
Departments of Endocrine Neoplasia and Hormonal Disorders (J.Y.X., C.J., S.N.R., M.A.H., S.G.W., R.D., R.F.G., A.K.Y., M.E.C., S.P.W., N.L.B., R.V.S., S.I.S., M.I.H.), Radiology (W.A.M.), Biostatistics (D.R.M.), and Endocrine Surgery (E.G.), University of Texas MD Anderson Cancer Center, Houston, Texas 77230-1402.
Robert F
RF
Gagel
Departments of Endocrine Neoplasia and Hormonal Disorders (J.Y.X., C.J., S.N.R., M.A.H., S.G.W., R.D., R.F.G., A.K.Y., M.E.C., S.P.W., N.L.B., R.V.S., S.I.S., M.I.H.), Radiology (W.A.M.), Biostatistics (D.R.M.), and Endocrine Surgery (E.G.), University of Texas MD Anderson Cancer Center, Houston, Texas 77230-1402.
Anita K
AK
Ying
Departments of Endocrine Neoplasia and Hormonal Disorders (J.Y.X., C.J., S.N.R., M.A.H., S.G.W., R.D., R.F.G., A.K.Y., M.E.C., S.P.W., N.L.B., R.V.S., S.I.S., M.I.H.), Radiology (W.A.M.), Biostatistics (D.R.M.), and Endocrine Surgery (E.G.), University of Texas MD Anderson Cancer Center, Houston, Texas 77230-1402.
Maria E
ME
Cabanillas
Departments of Endocrine Neoplasia and Hormonal Disorders (J.Y.X., C.J., S.N.R., M.A.H., S.G.W., R.D., R.F.G., A.K.Y., M.E.C., S.P.W., N.L.B., R.V.S., S.I.S., M.I.H.), Radiology (W.A.M.), Biostatistics (D.R.M.), and Endocrine Surgery (E.G.), University of Texas MD Anderson Cancer Center, Houston, Texas 77230-1402.
Steven P
SP
Weitzman
Departments of Endocrine Neoplasia and Hormonal Disorders (J.Y.X., C.J., S.N.R., M.A.H., S.G.W., R.D., R.F.G., A.K.Y., M.E.C., S.P.W., N.L.B., R.V.S., S.I.S., M.I.H.), Radiology (W.A.M.), Biostatistics (D.R.M.), and Endocrine Surgery (E.G.), University of Texas MD Anderson Cancer Center, Houston, Texas 77230-1402.
Naifa L
NL
Busaidy
Departments of Endocrine Neoplasia and Hormonal Disorders (J.Y.X., C.J., S.N.R., M.A.H., S.G.W., R.D., R.F.G., A.K.Y., M.E.C., S.P.W., N.L.B., R.V.S., S.I.S., M.I.H.), Radiology (W.A.M.), Biostatistics (D.R.M.), and Endocrine Surgery (E.G.), University of Texas MD Anderson Cancer Center, Houston, Texas 77230-1402.
Rena V
RV
Sellin
Departments of Endocrine Neoplasia and Hormonal Disorders (J.Y.X., C.J., S.N.R., M.A.H., S.G.W., R.D., R.F.G., A.K.Y., M.E.C., S.P.W., N.L.B., R.V.S., S.I.S., M.I.H.), Radiology (W.A.M.), Biostatistics (D.R.M.), and Endocrine Surgery (E.G.), University of Texas MD Anderson Cancer Center, Houston, Texas 77230-1402.
Elizabeth
E
Grubbs
Departments of Endocrine Neoplasia and Hormonal Disorders (J.Y.X., C.J., S.N.R., M.A.H., S.G.W., R.D., R.F.G., A.K.Y., M.E.C., S.P.W., N.L.B., R.V.S., S.I.S., M.I.H.), Radiology (W.A.M.), Biostatistics (D.R.M.), and Endocrine Surgery (E.G.), University of Texas MD Anderson Cancer Center, Houston, Texas 77230-1402.
Steven I
SI
Sherman
Departments of Endocrine Neoplasia and Hormonal Disorders (J.Y.X., C.J., S.N.R., M.A.H., S.G.W., R.D., R.F.G., A.K.Y., M.E.C., S.P.W., N.L.B., R.V.S., S.I.S., M.I.H.), Radiology (W.A.M.), Biostatistics (D.R.M.), and Endocrine Surgery (E.G.), University of Texas MD Anderson Cancer Center, Houston, Texas 77230-1402.
Mimi I
MI
Hu
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001859:Bone Neoplasms / Q000150:complications* / Q000453:epidemiology / Q000473:pathology* / Q000556:secondary; D018278:Carcinoma, Neuroendocrine / Q000453:epidemiology / Q000473:pathology*; D002648:Child; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D012042:Registries; D012189:Retrospective Studies; D013117:Spinal Cord Compression / Q000453:epidemiology / Q000209:etiology*; D016103:Spinal Fractures / Q000453:epidemiology / Q000209:etiology*; D013964:Thyroid Neoplasms / Q000453:epidemiology / Q000473:pathology*; D055815:Young Adult
Thyroid. 2015 Jun;25(6):567-610
25810047
Lancet Oncol. 2010 May;11(5):421-8
20362507
Cancer. 1997 Oct 15;80(8 Suppl):1588-94
9362426
J Clin Oncol. 2003 Aug 15;21(16):3150-7
12915606
J Clin Endocrinol Metab. 2013 Apr;98(4):1492-7
23436918
Int J Cancer. 2009 Oct 1;125(7):1705-9
19521984
Thyroid. 2014 Oct;24(10):1488-500
24921429
N Engl J Med. 2004 Apr 15;350(16):1655-64
15084698
Breast Cancer Res Treat. 2011 Sep;129(2):495-503
21461730
Thyroid. 2011 Jan;21(1):31-5
21058881
Lancet. 2012 Jan 7;379(9810):39-46
22093187
Lancet. 2015 Aug 1;386(9992):433-43
26040499
Eur Urol. 2015 Jul;68(1):42-50
25449207
Ann Surg Oncol. 2015 Nov;22(12):4008-13
25762482
Endocrinol Metab Clin North Am. 2014 Jun;43(2):423-42
24891170
N Engl J Med. 2009 Feb 12;360(7):679-91
19213681
Ann Oncol. 1994;5 Suppl 7:S41-4
7873461
J Natl Compr Canc Netw. 2010 May;8(5):549-56
20495084
Br J Cancer. 1987 Jan;55(1):61-6
3814476
J Bone Miner Res. 2008 Jun;23(6):826-36
18558816
J Clin Endocrinol Metab. 2007 Nov;92 (11):4185-90
17726071
Clin Endocrinol (Oxf). 1998 Mar;48(3):265-73
9578814
CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90
21296855
J Clin Endocrinol Metab. 2012 Jul;97(7):2433-9
22564664